Physician profile
Anina Bacon
NPI 1952739708
$859.47
in general payments reported to CMS, 2019-2025
14 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $245 · 2024: $477 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665 · Education: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $664.57 |
| Education | $194.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $194.90 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $156.61 | 2024 | Tezspire, Airsupra |
| Genzyme Corporation | $130.80 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $91.77 | 2023-2024 | Ofev |
| Regeneron Healthcare Solutions, INC. | $60.41 | 2024 | Dupixent |
| Jazz Pharmaceuticals INC. | $42.44 | 2023-2024 | |
| Inspire Medical Systems, INC. | $32.40 | 2025 | Inspire |
| Glaxosmithkline, LLC. | $32.13 | 2025 | Nucala |
| Takeda Pharmaceuticals U.S.A., INC. | $31.11 | 2023 | Glassia |
| Lilly USA, LLC | $19.06 | 2025 | Zepbound |
| Baxter Healthcare | $18.14 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Zoll Respicardia, INC. | $17.21 | 2025 | Remede System |
| Amgen INC. | $16.27 | 2025 | Tezspire |
| Philips North America LLC | $16.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anina Bacon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.